New North American Collaboration for FirstClinTech

24 May 2016

The Board of Directors at FirstClinTech is delighted to announce the start of a close collaboration with California-based Bayrock Medtech Advisors. This alliance will enhance FirstClinTech’s already excellent network of professionals dedicated to supporting the use of medical devices in Europe, Asia and Africa. In addition it will give FirstClinTech’s Clients a pathway to a highly effective support network in North America.

Jane Reedy - CEO of Bayrock

Jane Reedy – CEO of Bayrock

Jane Reedy, Bayrock’s founder and CEO, has a stellar record in the medical device industry, with experience as a senior executive of larger companies as well as start-ups. By leveraging a unique clinical background and unrivalled network of contacts around the world, Bayrock in the USA is able to offer medtech companies services including strategic and operational matters, reimbursement, clinical affairs, regulatory, sales and marketing.

Like FirstClinTech, Bayrock is determined to be very flexible, filling in the gaps that a CRO, a Distributor, or a manufacturer may struggle to fill. Both organisations recognise that cost effectiveness and sensible use of funds is key to success in developing new medical devices.

Rob Petterson, Co-founder of FirstClinTech, said “We have known Jane and Bayrock Medtech Advisors for a long time. We know that there is complete trust there, and we will happily suggest our Clients make use of Bayrock’s services. We are looking forward to seeing great benefits from this cooperation.”

Collaboration with Bayrock will bring FirstClinTech additional visibity in the vital US medical device start-up arena.


Jane Reedy, CEO of Bayrock, said “Our philosophy is essentially the same – a solid commitment to the patients, the doctors and their staff, and the companies and investors that develop these innovative medical devices. The collaboration between FirstClinTech and Bayrock will benefit our clients now and in the future.”

Andrew Harrison, Director of Finance at FirstClinTech, commented “Bayrock will bring us some additional visibity in the vital US medical device start-up arena. One of our key goals is to make our services known to early stage companies, and Bayrock can help us achieve that.”

Terry McCarthy, Managing Director of FirstClinTech, added “Jane share’s our values, and between our two companies we can offer our clients more options to ensure great clinical outcomes, excellence in studies – working together with our current partners – and solid business development thereafter.”

More information can be found at www.firstclintech.com and www.bayrockadvisors.com